Hepatocyte growth factor (HGF), heat shock proteins (HSPS) and multidrug resistance protein (MRP) expression in co-culture of colon tumor spheroids with normal cells after incubation with interleukin-1β (IL-1β and/or camptothecin (CPT-11)

Indian Journal of Experimental Biology

Volumn 48, Issue 4, 2010, Pages 354-364

  Paduch, Roman ^a   Jakubowicz Gil, Joanna ^a   Niedziela, Piotr ^b  

^a MARIA CURIE SK ODOWSKA UNIVERSITY   (Poland)

^b District Railway Hospital   (Poland)

Author keywords

Co culture; Colon carcinoma; Heat shock proteins; Hepatocyte growth factor; Multidrug resistance protein

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; GLYCOPROTEIN P; HEAT SHOCK PROTEIN; INTERLEUKIN 1BETA; SCATTER FACTOR;

ARTICLE; BIOSYNTHESIS; CANCER STAGING; COCULTURE; COLON; COLON TUMOR; CYTOLOGY; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; METABOLISM; MULTICELLULAR SPHEROID; PATHOLOGY; TUMOR CELL LINE; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BLOTTING, WESTERN; CAMPTOTHECIN; CELL LINE, TUMOR; COCULTURE TECHNIQUES; COLON; COLONIC NEOPLASMS; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HEAT-SHOCK PROTEINS; HEPATOCYTE GROWTH FACTOR; HUMANS; INTERLEUKIN-1BETA; NEOPLASM STAGING; P-GLYCOPROTEINS; SPHEROIDS, CELLULAR;

EID: 77954337326     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Fujishima H, Kikuchi I, Miyanaga O, Ueda A, Baba E, Mitsugi K, Harada M & Nakano S, Phase I study of CPT-11 and bolus 5-FU//-leucovorin in patients with metastatic colorectal cancer, Int J Clin Oncol, 9 (2004) 92.
2. Allegrini G, Goulette F A, Darnowski J W & Calabresi P, Thrombospondin-1 plus irinotecan: A novel antiangiogenic-chemotherapeutic combination that inhibits the growth of advanced human colon tumor xenografts in mice, Cancer Chemother Pharmacol, 53 (2004) 261.
3. Takemoto I, Itagaki S, Chiba M, Itoh T, Hirano T & Iseki K, Characterization of secretory intestinal transport of the lactone form of CPT-11, Cancer Chemother Pharmacol, 57 (2006) 129.
4. Arnould S, Guichard S, Hennebelle I, Cassar G, Bugat R & Canal P, Contribution of apoptosis in the cytotoxicity of the oxaliplatin-irinotecan combination in the HT29 human colon adenocarcinoma cell line, Biochem Pharmacol, 64 (2002) 1215.
5. Adlard J W, Richman S D, Seymour M T & Quirke P, Prediction of the response of colorectal cancer to systemic therapy, Lancet Oncol, 3 (2002) 75.
6. Stein U & Walther W, Cytokine-mediated reversal of multidrug resistance, Cytotechnology, 27 (1998) 271.
7. Ling V, Multidrug resistance: Molecular mechanisms and clinical relevance, Cancer Chemother Pharmacol, 40(Suppl.) (1997) S3.
8. Ouar Z, Lacave R, Bens & Vandewalle A, Mechanisms of altered sequestration and efflux of chemotherapeutic drugs by multidrug-resistant cells, Cell Biol Toxicol, 15 (1999) 91.
9. Litman T, Druley T E, Stein W D & Bates S E, From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance, Cell Mol Life Sci, 58 (2001) 931.
10. Wang Y, Pan X-Q Lheureux F & Georges E, Overexpression of a 40-kDa protein in human multidrug resistant cells, Biochem Biophys Res Commun, 236 (1997) 483.
11. Nanashima A, Yamaguchi H, Matsuo S, Sumida Y, Tsuji T, Sawai T, Yasutake T, Nakagoe T & Ayabe H, Expression of multidrug resistance protein in metastatic colorectal carcinomas, J Gastroenterol, 34 (1999) 582.
12. Yu X-Q, Xue Ch C, Wang G & Zhou S-F, Multidrug resistance associated proteins as determining factors of pharmacokinetics and pharmacodynamics of drugs, Curr Drug Metab, 8 (2007) 787.
13. Quan Z, Ozawa T, Sato M & Umezawa Y, Screening method for substrates of multidrug resistance-associated protein, Anal Chim Ada, 423 (2000) 197.
14. Paduch R, Jakubowicz-Gil J, Tustanowska-Stachura A, Slowinska M, Gawron A & Kandefer-Szerszen M, Cisplatin and etoposide combined therapy changes heat shock proteins (HSPs) expression in tumor cells, Ann Univ Mariae Curie-Sklodowska [Biol], LXII (2007) 55.
15. Jakubowicz-Gil J, Paduch R, Gawron A & Kandefer-Szerszen M, The effect of cisplatin, etoposide and quercetin on Hsp72 expression, Pol J Pathol, 53 (2002) 133.
16. Garrido C, Brunet M, Didelot C, Zermati Y, Schmitt E & Kroemer G, Heat shock proteins 27 and 70, Cell Cycle, 5 (2006) 2592.
17. Jakubowicz-Gil J, Pawlikowska-Pawlega B, Piersiak T, Pawelec J & Gawron A, Quercetin suppresses heat shock-induced nuclear translocation of Hsp72, Folia Histochem Cytobiol, 43 (2005) 123.
18. Kojima K, Musch M W, Ren H, Boone D L, Hendrickson B A, Ma A & Chang E B, Enteric flora and lymphocyte-derived cytokine determine expression of heat shock proteins in mouse colonic epithelial cells, Gastroenterology, 124 (2003) 1395.
19. Zhao L, Liu L, Wang S, Zhang Y-F, Yu L & Ding Y-Q, Differential proteomic analysis of human colorectal carcinoma cell lines metastasis-associated proteins, J Cancer Res Clin Oncol, 133 (2007) 771.
20. Dalton W S, The tumor microenvironment as a determinant of drug response and resistance, Drug Resist Update, 2 (1999) 285.
21. Kammula U S, Kuntz E J, Francone T D, Francone T D, Zeng Z, Shia J, Landmann R G, Paty P B & Weiser M R, Molecular co-expression of the c-Met oncogene and hepatocyte growth factor in primary colon cancer predicts tumor stage and clinical outcome, Cancer Lett, 248 (2007) 219.
22. Fazekas K, Csuka O, Köves I, Rásó E & Tímár J, Experimental and clinicopathologic studies on the function of the HGF receptor in human colon cancer metastasis, Clin Exp Metastasis, 18 (2001) 639.
23. Meng Q, Mason J M, Porti D, Goldberg I D, Rosen E M & Fan S, Hepatocyte growth factor decreases sensitivity to chemotherapeutic agents and stimulates cell adhesion, invasion and migration, Biochem Biophys Res Commun, 274 (2000) 772.
24. Xia S & Laterra J, Hepatocyte growth factor increases mitochondrial mass in glioblastoma cells, Biochem Biophys Res Commun, 345 (2006) 1358.
25. Apte R N & Voronov E, Interleukin-1-a major pleiotropic cytokine in tumor-host interactions, Semin Cancer Biol, 12 (2002) 277.
26. Paduch R & Kandefer-Szerszen M. Vitamin D, tamoxifen and P-estradiol modulate breast cancer growth and interleukin-6 and metalloproteinase-2 production in three-dimensional co-cultures of tumor cell spheroids with endothelium, Cell Biol Toxicol, 21 (2005) 247.
27. Wen J, Matsumoto K, Taniura N, Tomioka D & Nakamura T, Inhibition of colon growth and metastasis by NK4 gene repetitive delivery in mice, Biochem Biophys Res Commun, 358 (2007) 117.
28. Tomonaga M, Oka M, Narasaki F, Fukuda M, Nakano R, Takatani H, Ikeda K, Terashi K, Matsuo I, Soda H, Cowan K H & Kohno S, The multidrug resistance-associated protein gene confers drug resistance in human gastric and colon cancers, Jpn J Cancer Res, 87 (1996) 1263.
29. Rashmi R, Kumar S & Karunagaran D, Ectopic expression of Hsp70 confers resistance and silencing its expression sensitizes human colon cancer cells to curcumin-induced apoptosis, Carcinogenesis, 25 (2004) 179.
30. Lee J-H, Sun D, Cho K-J, Kim M-S, Hong M-H, Kim I-K, Lee J-S & Lee J-H, Overexpression of human 27 kDa heat shock protein in laryngeal cancer cells confers chemoresistance associated with cell growth delay, J Cancer Res Clin Oncol, 133 (2007) 37.
31. Choi D H, Ha J S, Lee W H, Song J K, Kim G Y, Park J H, Cha H J, Lee B J & Park J W, Heat shock protein 27 is associated with irinotecan resistance in human colorectal cancer cells, FEBS Lett, 581 (2007) 1649.
32. Wang X, Wang Q, Guo L, Ying X & Zhao Y, Immunolocalisation of heat shock protein 72 and glycoprotein 96 in colonic adenocarcinoma, Ada Histochem, 110 (2008) 117.
33. Crouch S, Spidel C S & Lindsey J S, HGF and ligation of av αvβ35 integrin induce a novel, cancer cell-specific gene expression required for cell scattering, Exp Cell Res, 292 (2004) 274.
34. Hiscox S & Jiang W G, Regulation of endothelial CD44 expression and endothelium - tumor cell interactions by hepatocyte growth factor/scatter factor, Biochem Biophys Res Commun, 233 (1997) 1.
35. Lewis A M, Varghese S, Xu H & Alexander H R, Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment, J Translat Med, 4 (2006) 48.
36. Maas-Szabowski N & Fusenig N E, Interleukin-1-induced growth factor expression in postmitotic and resting fibroblasts, J Invest Dermatol, 107 (1996) 849.
37. Min J K, Lee Y M, Kim J H, Kim Y M, Kim S W, Lee S Y, Gho Y S, Oh G T & Kwon Y G, Hepatocyte growth factor supresses vascular endothelial growth factor-induced expression of endothelial ICAM-1 and VCAM-1 by inhibiting the nuclear factor-KB pathway, Circ Res, 96 (2005) 300.
38. Hansen R K, Parra I, Lemieux P, Oesterreich S, Hilsenbeck S G & Fuqua S A W, Hsp27 overexpression inhibits doxorubicin-induced apoptosis in human breast cancer cells, Breast Cancer Res Treat, 56 (1999) 187.
39. Armand J P, Ducreux M, Mahjoubi M, Abigerges D, Bugat R, Chabot G, Herait P, de Forni M & Rougier P, CPT-11 (irinotecan) in the treatment of colorectal cancer, Eur J Cancer, 31A (1995) 1283.
40. Grivicich I, Regner A, Zanoni C, Correa L P, Jotz P, Henriques J A P, Schwartsmann G & da Rocha A B, Hsp70 response to 5-fluorouracil treatment in human colon cancer cell lines, Int J Colorectal Dis, 22 (2007) 1201.
41. Ho E A & Piquette-Miller M, Regulation of multidrug resistance by pro-inflammatory cytokines, Curr Cancer Drug Targets, 6 (2006) 295.
42. Abdul M & Hoosein N, Relationship of the interleukin-1 system with neuroendocrine and exocrine markers in human colon cancer cell lines, Cytokine, 18 (2002) 86.